Aurobindo Pharma Limited - Laporan Arus Kas (TTM)

Aurobindo Pharma Limited
IN ˙ BSE
₹ 1,212.10 ↓ -17.30 (-1.41%)
2025-05-02
BAHAGING PRESYO
Laporan Arus Kas (TTM)

Laporan Arus Kas Aurobindo Pharma Limited menunjukkan perubahan posisi kas dari waktu ke waktu. Data Laporan Arus Kas meliputi Kas dari Aktivitas Operasional (CFOP), Kas dari Aktivitas Investasi, dan Kas dari Aktivitas Pendanaan.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2021
03-31
2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
Cash From Operating Activities 42,542 33,290 28,769 50,165 52,208 23,868 19,946 24,345 15,867 39,246
Change (%) -21.75 -13.58 74.37 4.07 -54.28 -16.43 22.06 -34.83 147.35
% of Cash Flow 326.36 128.88 259.21 -429.71 -738.87 1,038.80 552.74 -241.80 -682.20 180.16
Cash From Investing Activities -15,250 5,987 -4,266 -32,116 -48,695 -39,778 -35,336 -42,560 -19,029 -18,758
Change (%) -139.26 -171.26 652.77 51.62 -18.31 -11.17 20.44 -55.29 -1.43
% of Cash Flow -116.99 23.18 -38.44 275.10 689.14 -1,731.26 -979.25 422.70 818.18 -86.11
Cash From Financing Activities -14,234 -13,649 -13,676 -29,693 -10,599 18,144 18,952 8,004 530 1,198
Change (%) -4.11 0.20 117.11 -64.30 -271.18 4.45 -57.77 -93.38 125.96
% of Cash Flow -109.20 -52.84 -123.22 254.35 150.01 789.70 525.20 -79.50 -22.79 5.50
Cash Flow 13,035 25,831 11,099 -11,674 -7,066 2,298 3,608 -10,068 -2,326 21,784
Change (%) 98.16 -57.03 -205.18 -39.47 -132.52 57.06 -379.02 -76.90 -1,036.61
% of Cash Flow 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Source: Capital IQ

Other Listings
IN:AUROPHARMA ₹ 1,044.40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista